AB Clinical Trials
Las Vegas, Nevada, United States
Medical office in Paradise, Nevada
2110 E Flamingo Rd Suite 103, Las Vegas, NV 89119
About AB Clinical Trials
"We are an experienced clinical research company bringing quality care to our community via phase 1-4 trials. People think you are a “guinea pig” if you participate in studies. This is not true as 60% of the medications or devices provided are on the market. You are guaranteed to see a physician, not PA or NP, who has a background that includes Yale University and UCSF. But most importantly, you will be heard here as we care about all those we are honored to treat. We are an appointment only facility."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Pfizer
2
Elcelyx Therapeutics, Inc.
1
Gilead Sciences
1
ImmusanT, Inc.
1
ModernaTX, Inc.
1
NewAmsterdam Pharma
1
Novartis Pharmaceuticals
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
SK Life Science, Inc.
1
Shionogi
1
Clinical Trials at AB Clinical Trials
During the past decade, AB Clinical Trials conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on
average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
2011-03-01
2012-07-01
Completed
441
Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)
2010-12-01
2011-11-01
Completed
439
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
2013-10-01
2014-12-01
Completed
334
A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes
2014-05-01
2015-10-01
Completed
300
A Study of LY2623091 in Participants With High Blood Pressure
2014-08-01
2015-03-01
Completed
304
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
2015-09-01
2016-09-01
Completed
571
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "AB Clinical Trials" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Elcelyx Therapeutics, Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "ImmusanT, Inc."
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "AB Clinical Trials"
#1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at AB Clinical Trials
According to Clinical.Site data, the most researched conditions in "AB Clinical Trials" are
"Atherosclerotic Cardiovascular Disease" (2 trials), "Cardiovascular Disease" (2 trials), "Autoimmune Diseases" (1 trials), "COVID-19" (1 trials) and "Celiac" (1 trials). Many other conditions were trialed in "AB Clinical Trials" in a lesser frequency.
Clinical Trials Intervention Types at AB Clinical Trials
Most popular intervention types in "AB Clinical Trials" are "Drug" (13 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "bococizumab (PF-04950615)" (2 trials), "Dulaglutide" (1 trials), "Inclisiran sodium 300 mg" (1 trials) and "Insulin Glargine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AB Clinical Trials
The vast majority of trials in "AB Clinical Trials" are
15 trials for "All" genders.
Clinical Trials Status at AB Clinical Trials
Currently, there are NaN active trials in "AB Clinical Trials".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in AB Clinical Trials,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in AB Clinical Trials, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".